(Press-News.org) An international research team led by Dr. Cindy Leissinger of Tulane University School of Medicine, along with Dr. Alessandro Gringeri from the University of Milan, has found that a drug commonly used to treat bleeding events in people with a type of severe hemophilia can also be used to prevent such events from happening in the first place. The study, the first to confirm the efficacy and safety of the drug FEIBA™ in bleed prevention is published in the Nov. 3, 2011 issue of the New England Journal of Medicine.
The study examined the ability of FEIBA to prevent bleeds in people with severe hemophilia A with inhibitors. People with this condition produce antibodies known as inhibitors. These inhibitors render ineffective the usual treatment for hemophilia, which involves replacement of the blood clotting factor (Factor VIII) that is absent in hemophilia patients. Approximately 30 percent of patients with severe hemophilia A develop such "inhibitor" antibodies. Hemophilia A patients with inhibitors require treatments with alternate forms of clotting factor concentrates, known as bypassing agents, and until recently primarily had to be infused with clotting factors "on demand" as bleeding episodes occur. Treatment of bleeding events in these patients is not always effective, leading to significant problems for patients, who typically experience repeated joint bleeding and progressive joint disease.
The Tulane-led study tested if preventive treatment with the bypassing agent FEIBA is safe and effective in preventing joint and other bleeds in hemophilia A patients with inhibitors. Thirty-four patients were enrolled for the 15-month-long study.
The study showed that, compared to on-demand therapy, FEIBA infused three times per week resulted in an overall reduction of 62 percent in all bleeding events and a 72 percent reduction in target joint bleeding ("target joints" are joints that experience repetitive bleeding). Nearly two-thirds of patients showed a very good response to preventive FEIBA treatment, experiencing a reduction in bleeding events of 82 percent.
### END
Tulane-led study first to confirm effectiveness and safety of new treatment for hemophilia
2011-11-03
ELSE PRESS RELEASES FROM THIS DATE:
Chantix unsuitable for first-line smoking cessation use
2011-11-03
WINSTON-SALEM, N.C. -- The poor safety profile of the smoking-cessation drug varenicline (Chantix™) makes it unsuitable for first-line use, according to a study published in the Nov. 2 edition of the journal PLoS One, an online publication of the Public Library of Science.
Varenicline, which already carries a "black box warning" from the U.S. Food and Drug Administration (FDA), showed a substantially increased risk of reported depression or suicidal behavior compared to other smoking-cessation treatments, according to researchers at Wake Forest Baptist Medical Center, ...
Jewelry By Morgan Receives the 2011 Talk of the Town Award
2011-11-03
Kansas City Jeweler Jewelry By Morgan has been named a recipient of the 2011 Customer Satisfaction Award for Excellence in Customer Care, presented by Talk of the Town News, Customer Care News and Celebration Media.
The award honors companies and professionals that provide excellent customer service, as reported by their customers through no-cost, user review websites. The reviews are analyzed by a team of researchers who calculate a star rating system based on these data, which determines a business' award eligibility.
"Customer service has always been incredibly ...
3-D long-term bone marrow culture to analyze stromal cell biological function
2011-11-03
Stromal cells, as distinct from hematopoietic cells, are an essential component of the bone marrow microenvironment and are necessary for the long-term maintenance of hematopoietic stem cells (HSCs) in vitro. Previous studies have shown that stromal cells regulate the proliferation and differentiation of HSCs through the production of diffusible hematopoietic regulatory factors and extracellular matrix, and through physical cell-cell interactions involving adhesion molecules and gap junction-mediated cell communication. However, the ability of stromal cells to support the ...
Chemical engineers help decipher mystery of neurofibrillary tangle formation in Alzheimer's brains
2011-11-03
Neurofibrillary tangles – odd, twisted clumps of protein found within nerve cells – are a pathological hallmark of Alzheimer's disease. The tangles, which were first identified in the early 1900s by German psychiatrist and neuropathologist Aloysius Alzheimer, are formed when changes in a protein called tau cause it to aggregate in an insoluble mass in the cytoplasm of cells. Normally, the tau protein is involved in the formation of microtubules, hollow filaments that provide cells with support and structure; abnormal tau tangles, however, cause that structure to break down, ...
Graphene applications in electronics and photonics
2011-11-03
Graphene, which is composed of a one-atom-thick layer of carbon atoms in a honeycomb-like lattice (like atomic-scale chicken wire), is the world's thinnest material – and one of the hardest and strongest. Indeed, the past few years have seen an explosion of research into the properties and potential applications of graphene, which has been touted as a superior alternative to silicon.
Because graphene is a two-dimensional material, "all of it is an exposed surface," says physical chemist Phaedon Avouris, manager of the Nanometer Scale Science and Technology division at ...
Researchers reveal potential treatment for sickle cell disease
2011-11-03
Ann Arbor, Mich. -- A University of Michigan Health System laboratory study reveals a key trigger for producing normal red blood cells that could lead to a new treatment for those with sickle cell disease.
The study, conducted in mice, appears in this week's early edition of the Proceedings of the National Academy of Sciences, and holds promise for preventing the painful episodes and organ damage that are common complications of sickle cell disease.
According to the U-M study, increasing the expression of the proteins, TR2 and TR4, more than doubled the level of fetal ...
A hormone ensures its future
2011-11-03
Much of the body's chemistry is controlled by the brain – from blood pressure to appetite to food metabolism. In a study published recently in Developmental Cell, a team of scientists led by Dr. Gil Levkowitz of the Weizmann Institute has revealed the exact structure of one crucial brain area in which biochemical commands are passed from the brain cells to the bloodstream and from there to the body. In the process, they discovered a surprising new role for the 'hormone of love,' showing that it helps to direct the development of this brain structure.
The area in question, ...
Unraveling Batten disease
2011-11-03
Waste management is a big issue anywhere, but at the cellular level it can be a matter of life and death. A Weizmann Institute study, published in the Journal of Cell Biology, has revealed what causes a molecular waste container in the cell to overflow in Batten disease, a rare but fatal neurodegenerative disorder that begins in childhood. The findings may form the basis for a therapy for this disorder.
In Batten disease, an insoluble yellow pigment accumulates in the brain's neurons, causing these cells to degenerate and ultimately die. Patients gradually become disabled, ...
Humanities researchers and digital technologies: Building infrastructures for a new age
2011-11-03
Europe's leading scientists have pledged to embrace and expand the role of technology in the Humanities. In a Science Policy Briefing released today by the European Science Foundation (ESF), they argue that without Research Infrastructures (RIs) such as archives, libraries, academies, museums and galleries, significant strands of Humanities research would not be possible. By drawing on a number of case studies, the report demonstrates that digital RIs offer Humanities scholars new and productive ways to explore old questions and develop new ones.
According to Professor ...
Mediterranean diet and exercise can reduce sleep apnea symptoms
2011-11-03
Eating a Mediterranean diet combined with physical activity can help to improve some of the symptoms of sleep apnoea, according to new research.
The study, which is published online in the European Respiratory Journal, looked at the impact a Mediterranean diet can have on obese people with sleep apnoea, compared to those on a prudent diet.
Obstructive sleep apnoea syndrome (OSAS) causes frequent pauses of breathing to occur during sleep, which disrupts a person's normal sleeping pattern. It is one of the most prevalent sleep-related breathing disorders with approximately ...